A citation-based method for searching scientific literature

Obireddy Sreekanth Reddy, Wing-Fu Lai. Chembiochem 2021
Times Cited: 10







List of co-cited articles
21 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.
Yousuke Furuta, Takashi Komeno, Takaaki Nakamura. Proc Jpn Acad Ser B Phys Biol Sci 2017
405
50

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
30



Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial.
Zarir F Udwadia, Pawan Singh, Hanmant Barkate, Saiprasad Patil, Shabbir Rangwala, Amol Pendse, Jatin Kadam, Wen Wu, Cynthia F Caracta, Monika Tandon. Int J Infect Dis 2021
58
30

The mechanism of resistance to favipiravir in influenza.
Daniel H Goldhill, Aartjan J W Te Velthuis, Robert A Fletcher, Pinky Langat, Maria Zambon, Angie Lackenby, Wendy S Barclay. Proc Natl Acad Sci U S A 2018
127
20

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Calvin J Gordon, Egor P Tchesnokov, Emma Woolner, Jason K Perry, Joy Y Feng, Danielle P Porter, Matthias Götte. J Biol Chem 2020
373
20

Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19.
Richard T Eastman, Jacob S Roth, Kyle R Brimacombe, Anton Simeonov, Min Shen, Samarjit Patnaik, Matthew D Hall. ACS Cent Sci 2020
263
20

Coronavirus Disease 2019 (COVID-19): A Perspective from China.
Zi Yue Zu, Meng Di Jiang, Peng Peng Xu, Wen Chen, Qian Qian Ni, Guang Ming Lu, Long Jiang Zhang. Radiology 2020
623
20

Mechanism of action of T-705 against influenza virus.
Yousuke Furuta, Kazumi Takahashi, Masako Kuno-Maekawa, Hidehiro Sangawa, Sayuri Uehara, Kyo Kozaki, Nobuhiko Nomura, Hiroyuki Egawa, Kimiyasu Shiraki. Antimicrob Agents Chemother 2005
330
20

Favipiravir (T-705), a novel viral RNA polymerase inhibitor.
Yousuke Furuta, Brian B Gowen, Kazumi Takahashi, Kimiyasu Shiraki, Donald F Smee, Dale L Barnard. Antiviral Res 2013
499
20


A new coronavirus associated with human respiratory disease in China.
Fan Wu, Su Zhao, Bin Yu, Yan-Mei Chen, Wen Wang, Zhi-Gang Song, Yi Hu, Zhao-Wu Tao, Jun-Hua Tian, Yuan-Yuan Pei,[...]. Nature 2020
20

Role of favipiravir in the treatment of COVID-19.
Shashank Joshi, Jalil Parkar, Abdul Ansari, Agam Vora, Deepak Talwar, Mangesh Tiwaskar, Saiprasad Patil, Hanmant Barkate. Int J Infect Dis 2021
55
20

Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP.
Katerina Naydenova, Kyle W Muir, Long-Fei Wu, Ziguo Zhang, Francesca Coscia, Mathew J Peet, Pablo Castro-Hartmann, Pu Qian, Kasim Sader, Kyle Dent,[...]. Proc Natl Acad Sci U S A 2021
34
20

Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis.
Ashleigh Shannon, Barbara Selisko, Nhung-Thi-Tuyet Le, Johanna Huchting, Franck Touret, Géraldine Piorkowski, Véronique Fattorini, François Ferron, Etienne Decroly, Chris Meier,[...]. Nat Commun 2020
80
20

In vitro and in vivo activities of anti-influenza virus compound T-705.
Y Furuta, K Takahashi, Y Fukuda, M Kuno, T Kamiyama, K Kozaki, N Nomura, H Egawa, S Minami, Y Watanabe,[...]. Antimicrob Agents Chemother 2002
294
20


A novel LC-MS/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma: Application to a bioequivalence study in Egyptian human volunteers.
Mosaad I Morsy, Eman G Nouman, Youmna M Abdallah, Mourd A Zainelabdeen, Mohamed M Darwish, Ahmed Y Hassan, Amira S Gouda, Mamdouh R Rezk, Ahmed M Abdel-Megied, Hoda M Marzouk. J Pharm Biomed Anal 2021
4
50


Green micellar solvent-free HPLC and spectrofluorimetric determination of favipiravir as one of COVID-19 antiviral regimens.
Ibraam E Mikhail, Heba Elmansi, Fathalla Belal, Adel Ehab Ibrahim. Microchem J 2021
4
50

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.
Andrea J Pruijssers, Amelia S George, Alexandra Schäfer, Sarah R Leist, Lisa E Gralinksi, Kenneth H Dinnon, Boyd L Yount, Maria L Agostini, Laura J Stevens, James D Chappell,[...]. Cell Rep 2020
211
10

Coronavirus Infections-More Than Just the Common Cold.
Catharine I Paules, Hilary D Marston, Anthony S Fauci. JAMA 2020
779
10


Favipiravir-induced fever in coronavirus disease 2019: A report of two cases.
Hiroyuki Takoi, Yuki Togashi, Daiki Fujimori, Haruki Kaizuka, Shunsuke Otsuki, Takuya Wada, Yoshikazu Takeuchi, Shinji Abe. Int J Infect Dis 2020
5
20

Coronavirus infections and immune responses.
Geng Li, Yaohua Fan, Yanni Lai, Tiantian Han, Zonghui Li, Peiwen Zhou, Pan Pan, Wenbiao Wang, Dingwen Hu, Xiaohong Liu,[...]. J Med Virol 2020
759
10

Bat origin of human coronaviruses.
Ben Hu, Xingyi Ge, Lin-Fa Wang, Zhengli Shi. Virol J 2015
184
10

Drug repurposing approach to fight COVID-19.
Thakur Uttam Singh, Subhashree Parida, Madhu Cholenahalli Lingaraju, Manickam Kesavan, Dinesh Kumar, Raj Kumar Singh. Pharmacol Rep 2020
95
10

SARS and MERS: recent insights into emerging coronaviruses.
Emmie de Wit, Neeltje van Doremalen, Darryl Falzarano, Vincent J Munster. Nat Rev Microbiol 2016
10

The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.
Yongshi Yang, Fujun Peng, Runsheng Wang, Ming Yange, Kai Guan, Taijiao Jiang, Guogang Xu, Jinlyu Sun, Christopher Chang. J Autoimmun 2020
336
10

Compassionate Use of Remdesivir for Patients with Severe Covid-19.
Jonathan Grein, Norio Ohmagari, Daniel Shin, George Diaz, Erika Asperges, Antonella Castagna, Torsten Feldt, Gary Green, Margaret L Green, François-Xavier Lescure,[...]. N Engl J Med 2020
10

Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment.
Subramanian Boopathi, Adolfo B Poma, Ponmalai Kolandaivel. J Biomol Struct Dyn 2021
205
10

Emergency Use Authorization for Remdesivir and Its Potential Implications.
Cassius Iyad Ochoa Chaar, Robert Makuch. Ther Innov Regul Sci 2021
3
33

2019 Novel coronavirus: where we are and what we know.
Zhangkai J Cheng, Jing Shan. Infection 2020
225
10

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
Maria L Agostini, Erica L Andres, Amy C Sims, Rachel L Graham, Timothy P Sheahan, Xiaotao Lu, Everett Clinton Smith, James Brett Case, Joy Y Feng, Robert Jordan,[...]. mBio 2018
708
10

Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.
Luca Carsana, Aurelio Sonzogni, Ahmed Nasr, Roberta Simona Rossi, Alessandro Pellegrinelli, Pietro Zerbi, Roberto Rech, Riccardo Colombo, Spinello Antinori, Mario Corbellino,[...]. Lancet Infect Dis 2020
577
10

The reproductive number of COVID-19 is higher compared to SARS coronavirus.
Ying Liu, Albert A Gayle, Annelies Wilder-Smith, Joacim Rocklöv. J Travel Med 2020
10

Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses.
Dustin Siegel, Hon C Hui, Edward Doerffler, Michael O Clarke, Kwon Chun, Lijun Zhang, Sean Neville, Ernest Carra, Willard Lew, Bruce Ross,[...]. J Med Chem 2017
284
10

Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence.
Lisheng Wang, Yiru Wang, Dawei Ye, Qingquan Liu. Int J Antimicrob Agents 2020
344
10

Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019.
Eri Koshi, Shoji Saito, Masaki Okazaki, Yuki Toyama, Takuji Ishimoto, Tomoki Kosugi, Hiroaki Hiraiwa, Naruhiro Jingushi, Takanori Yamamoto, Masayuki Ozaki,[...]. CEN Case Rep 2021
9
11

Computational-aided design: minimal peptide sequence to block dengue virus transmission into cells.
Aathe Cangaree Arumugam, Fatima Ezzahra Agharbaoui, Ahmad Suhail Khazali, Rohana Yusof, Noorsaadah Abd Rahman, Abdullah Al Hadi Ahmad Fuaad. J Biomol Struct Dyn 2020
6
16



Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials.
Yujiro Yokoyama, Alexandros Briasoulis, Hisato Takagi, Toshiki Kuno. Virus Res 2020
20
10

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.
Hussin A Rothan, Siddappa N Byrareddy. J Autoimmun 2020
10

Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Xue-Yan Zhang, Hao-Jie Huang, Dong-Lin Zhuang, Moussa Ide Nasser, Ming-Hua Yang, Ping Zhu, Ming-Yi Zhao. Infect Dis Poverty 2020
24
10


Remdesivir for the Treatment of Covid-19 - Final Report.
John H Beigel, Kay M Tomashek, Lori E Dodd, Aneesh K Mehta, Barry S Zingman, Andre C Kalil, Elizabeth Hohmann, Helen Y Chu, Annie Luetkemeyer, Susan Kline,[...]. N Engl J Med 2020
10

Case report study of the first five COVID-19 patients treated with remdesivir in France.
Marie Dubert, Benoit Visseaux, Valentina Isernia, Lila Bouadma, Laurène Deconinck, Juliette Patrier, Paul-Henri Wicky, Diane Le Pluart, Laura Kramer, Christophe Rioux,[...]. Int J Infect Dis 2020
13
10

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission.
Xintian Xu, Ping Chen, Jingfang Wang, Jiannan Feng, Hui Zhou, Xuan Li, Wu Zhong, Pei Hao. Sci China Life Sci 2020
905
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.